건강 정책

팔로우
Elderly woman distressed by nursing home bill over 3200 euros monthly in Germany, with rising cost graph and empty savings.
AI에 의해 생성된 이미지

Nursing home costs rise above 3200 euros monthly

AI에 의해 보고됨 AI에 의해 생성된 이미지

Monthly out-of-pocket costs for nursing homes in Germany have risen further at the start of 2026. According to AOK and vdek data, the national average in the first year is around 3200 to 3245 euros. Insurers' associations are calling for reform to limit the burden.

The German federal government plans to eliminate free co-insurance for spouses in statutory health and long-term care insurance. The move aims to plug budget shortfalls at health insurance funds and will make coverage more expensive for many families. Handelsblatt learned of this from coalition sources.

AI에 의해 보고됨

개정된 조례에 따라 6월부터 대마초에서 추출한 CBN이 함유된 소비자 제품이 금지됩니다. 대체 치료법이 없는 난치성 질환 등 특정 질환을 앓고 있는 환자만 사용할 수 있게 됩니다.

Jens Baas, head of the Techniker Krankenkasse, anticipates higher contributions in statutory health insurance next year. The reasons include failed savings plans by Health Minister Nina Warken and required reserve building by the funds. Without a compromise in the mediation committee, additional payments could exceed three percent.

AI에 의해 보고됨 사실 확인됨

With the December 7 deadline approaching, about 68 million Americans covered by Medicare must decide on their health coverage for 2026. University of Michigan research finds that many do not use available comparison tools, potentially leading to higher costs and less suitable coverage. Experts urge beneficiaries to rely on official resources and independent counseling to navigate their options.

The U.S. House of Representatives narrowly passed legislation aimed at increasing transparency in hospital pricing on September 12, 2024. The measure, sponsored by Republicans, requires hospitals to disclose standard charges for services in advance. The bill now moves to the Senate amid partisan divides.

AI에 의해 보고됨

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부